Closed
15.17 3.2
24h
Min
15.06
Max
15.34
Income | 19M -41M |
---|---|
Sales | 6.9M 82M |
EPS | -0.19 |
Profit margin | -50.44 |
Employees | 385 |
EBITDA | 20M -26M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +125.46% upside |
Next Earnings | 31 lip 2025 |
---|
Market Cap | -340M 1.4B |
---|---|
Previous open | 11.97 |
Previous close | 15.17 |
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 34.54 USD 125.46%
High 47 USD
Low 22 USD
Based on 14 Wall Street analysts offering 12 month price targets forTravere Therapeutics Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$